Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/13/17
End: 01/18/18
Due: 01/18/19
Phase: N/A
Priority: Normal
Start: 03/25/17
End: 04/12/18
Due: 04/12/19
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study Comparing TPI-120 and Neulasta Administered Through Subcutaneous Route in Healthy Adult Subjects | NCT03206229 | Adello Biologics, LLC | user2@example.com | None | 2017-02-13 | 2018-01-18 | 2019-01-18 | - | - | 2025-07-14 |
| Comparative Immunogenicity Study Comparing TPI-120 to Neulasta® in Healthy Adult Subjects | NCT03202927 | Adello Biologics, LLC | user2@example.com | None | 2017-03-25 | 2018-04-12 | 2019-04-12 | - | - | 2025-07-14 |